Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 13;12(3):669.
doi: 10.3390/cancers12030669.

Sexual Dimorphism in Cellular and Molecular Features in Human ACTH-Secreting Pituitary Adenomas

Affiliations

Sexual Dimorphism in Cellular and Molecular Features in Human ACTH-Secreting Pituitary Adenomas

Francesca Pecori Giraldi et al. Cancers (Basel). .

Abstract

(1) Background. Cushing's disease presents gender disparities in prevalence and clinical course. Little is known, however, about sexual dimorphism at the level of the corticotrope adenoma itself. The aim of the present study was to evaluate molecular features of ACTH-secreting pituitary adenomas collected from female and male patients with Cushing's disease. (2) Methods. We analyzed 153 ACTH-secreting adenomas collected from 31 men and 122 women. Adenomas were established in culture and ACTH synthesis and secretion assessed in basal conditions as well as during incubation with CRH or dexamethasone. Concurrently, microarray analysis was performed on formalin-fixed specimens and differences in the expression profiles between specimens from male and female patients identified. (3) Results. ACTH medium concentrations in adenomas obtained from male patients were significantly lower than those observed in adenomas from female patients. This could be observed for baseline as well as modulated secretion. Analysis of corticotrope transcriptomes revealed considerable similarities with few, selected differences in functional annotations. Differentially expressed genes comprised genes with known sexual dimorphism, genes involved in tumour development and genes relevant to pituitary pathophysiology. (4) Conclusions. Our study shows for the first time that human corticotrope adenomas present sexual dimorphism and underlines the need for a gender-dependent analysis of these tumours. Differentially expressed genes may represent the basis for gender-tailored target therapy.

Keywords: ACTH-secreting adenomas; Cushing’s disease; gender; gene expression profiling; neuroendocrine tumours.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Volcano plot. Genes up- and down-regulated specimens from male vs. female patients. Effect (ratio of average signal, AVG) is shown on the x-axis and significance (Diff Score) on the y-axis. Up-regulated genes appear to the right and down-regulated genes appear to the left on the x-axis. White circles indicate significant genes (Diff Score > 13) and selected genes are identified by name.

References

    1. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations. Johns Hopkins Bull. 1932;50:137–195. - PubMed
    1. Cavagnini F., Pecori Giraldi F. Epidemiology and follow-up of patients with Cushing’s disease. Ann. Endocrinol. 2001;62:168–179. - PubMed
    1. Pecori Giraldi F., Moro M., Cavagnini F., the Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis Gender-related differences in the presentation and course of Cushing’s disease. J. Clin. Endocrinol. Metab. 2003;88:1554–1558. doi: 10.1210/jc.2002-021518. - DOI - PubMed
    1. Patil C.G., Lad S.P., Harsh G.R., Laws E.R., Jr., Boakye M. National trends, complications, and outcomes following transsphenoidal surgery for Cushing’s disease from 1993 to 2002. Neurosurg. Focus. 2007;23:E7–E12. doi: 10.3171/foc.2007.23.3.9. - DOI - PubMed
    1. Castinetti F., Guignat L., Giraud P., Muller M., Kamenicky P., Drui D., Caron P., Luca F., Donadille B., Vantyghem M.C., et al. Ketoconazole in Cushing’s disease: Is it worth a try? J. Clin. Endocrinol. Metab. 2014;99:1623–1630. doi: 10.1210/jc.2013-3628. - DOI - PubMed